⭐️⭐️⭐️⭐️⭐️ "A total no brainer"

⭐️⭐️⭐️⭐️⭐️ "Love this, so easy."

Spots is the easy way to track your skin, mole and cancer changes.

Spots Global Cancer Trial Database for placebo capsule

Every month we try and update this database with for placebo capsule cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.

The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.

Study titleNCT IDConditionsInterventionsEligibilityOrganizationLink
Maintenance Treatment With BGB-290 Versus Placebo in Participants With Platinum-sensitive Recurrent Ovarian CancerNCT03519230
Ovarian Cancer
Pamiparib capsu...
Placebo capsule
18 Years - BeiGene
Weight Loss Plus Omega-3 Fatty Acids or Placebo in High Risk WomenNCT02101970
Breast Cancer
Omega-3 Fatty A...
Placebo Capsule
Diet and Exerci...
45 Years - 70 YearsUniversity of Kansas Medical Center
A Study of BPI-7711 Capsule in Non-small Cell Lung Cancer PatientsNCT03866499
NSCLC
BPI-7711
Gefitinib
Placebo Tablet
Placebo capsule
18 Years - Beta Pharma, Inc.
Phase II Study of Anlotinib in Patients With Advanced Non-small Cell Lung Cancer(ALTER0302)NCT01924195
Non-small Cell ...
Anlotinib
Placebo capsule
18 Years - 70 YearsChia Tai Tianqing Pharmaceutical Group Co., Ltd.
Maintenance Treatment With BGB-290 Versus Placebo in Participants With Platinum-sensitive Recurrent Ovarian CancerNCT03519230
Ovarian Cancer
Pamiparib capsu...
Placebo capsule
18 Years - BeiGene
Phase II Study of Anlotinib in Patients With Advanced Non-small Cell Lung Cancer(ALTER0302)NCT01924195
Non-small Cell ...
Anlotinib
Placebo capsule
18 Years - 70 YearsChia Tai Tianqing Pharmaceutical Group Co., Ltd.
To Predict Efficacy by Detecting Circulating Endothelial Cell Subsets and Blood Perfusion Parameters Changes in Vivo Tumor in the Phase II/III Study of Anlotinib in Patients With Advanced Non-small Cell Lung CancerNCT02029209
Non-small Cell ...
Anlotinib
Placebo Capsule
18 Years - 70 YearsChia Tai Tianqing Pharmaceutical Group Co., Ltd.
Maintenance Treatment With BGB-290 Versus Placebo in Participants With Platinum-sensitive Recurrent Ovarian CancerNCT03519230
Ovarian Cancer
Pamiparib capsu...
Placebo capsule
18 Years - BeiGene
The Effect of Green Tea and Vitamin C on Skin HealthNCT01032031
Skin Cancer
Green tea + vit...
Placebo capsule
18 Years - 65 YearsUniversity of Manchester
Vitamin D in Postmenopausal Women at High Risk for Breast CancerNCT00859651
Breast Cancer
Cholecalciferol
Placebo capsule
21 Years - Columbia University
Chemotherapy Combined With Yangzhengxiaoji Capsule in Patients With Advanced Non-Small Cell Lung CancerNCT02195453
Non-Small Cell ...
Yangzhengxiaoji...
Placebo Capsule
18 Years - 70 YearsShandong Cancer Hospital and Institute
A Study of Two Different Doses of Cabozantinib (XL184) in Progressive, Metastatic Medullary Thyroid CancerNCT01896479
Medullary Thyro...
Cabozantinib (X...
Cabozantinib (X...
Placebo tablet
Placebo capsule
18 Years - Exelixis
Logo

Take Control of Your Skin and Body Changes Today.

Try out Spots for free, set up only takes 2 mins.

spots app storespots app store

Join others from around the world: